4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Compass Therapeutics, Inc. (CMPX) operates in the Biotechnology industry and is headquartered in Boston, United States with about 39 employees. Its market capitalization is roughly $385 million. In the fiscal year ended 2025-12-31, CMPX reported $0M in revenue and ($66M) in net income.
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, develops antibody-based therapeutics for the treatment of various human diseases in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $1M | $0M | $0M | — |
| Operating Income (EBIT) | ($73M) | ($57M) | ($50M) | ($42M) | — |
| Net Income | ($66M) | ($49M) | ($42M) | ($39M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($20M) | ($18M) | ($16M) | ($21M) | ($18M) | — |
| Net Income | ($18M) | ($16M) | ($14M) | ($20M) | ($17M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $220M | $140M | $157M | $200M | — |
| Total Liabilities | $23M | $15M | $8M | $18M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CMPX viewer.
About TickerBase · Data methodology & sources